Fig. 1: Individual laboratory parameters over time in cytopenic patients in relation to PARPi treatment. | Leukemia

Fig. 1: Individual laboratory parameters over time in cytopenic patients in relation to PARPi treatment.

From: Monitoring clone dynamics and reversibility in clonal haematopoiesis and myelodysplastic neoplasm associated with PARP inhibitor therapy—a role for early monitoring and intervention

Fig. 1

A Patient 1: haemoglobin concentration, mean cell volume (MCV), platelet count and transfusion requirement in relation to chemotherapy (blue) and PARPi treatment (grey). B Patient 2: haemoglobin concentration, MCV, red cell distribution width (RDW) and transfusion requirement in relation to chemotherapy and PARPi treatment. C Patient 3: haemoglobin concentration, MCV and RDW in relation to PARPi treatment. D Patient 4: haemoglobin concentration, MCV and platelet count in relation to chemotherapy and PARPi treatment.

Back to article page